Interestingly, BMI1 regulates both Cdkn2a and the BMP pathway independently, and BMI1 expression was shown to be decreased in AD patients compared to age-matched controls (Flamier et al., 2018). This evidence concerns the gene BMI1 and Alzheimer disease.